AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 171 min read$THC

KERREY J ROBERT sold $3.2M of THC

KERREY J ROBERT sold 12,010 shares of TENET HEALTHCARE CORP (THC) at an average of $263.72 ($263.04–$264.62, $3.17M total) across 3 trades on 2026-09-14.

Original reporting
SEC EDGAR · KERREY J ROBERT
Published Sep 17, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 12:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

The director's divestiture may be interpreted as a negative signal, but the modest remaining stake limits impact.

02

Market read

Primary relevance to THC shareholders; minimal spillover to broader market.

03

What to watch

No disclosed reason for the sale; could be personal liquidity needs rather than lack of confidence.

Relevance 6/10Novelty 5/10Timing: post‑filing 2026‑09‑16

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the sale.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

Director Kerrey J. Robert sold 12,010 shares for $3.17M, reducing his stake to 4,794 shares.

Expected impact

Modest downside pressure; price could dip 1‑2% in the next trading session.

Evidence & confidence

A $3.2M sale by a director is material but not unusually large for Tenet; market may view it as a neutral to slightly bearish signal.

Market effects

Sector

Healthcare services sector may see slight scrutiny of insider activity but no broad impact.

Regional

U.S. market; limited regional effect.

Global

Low; relevance confined to Tenet Healthcare investors.

Counterpoint

What could challenge this read

The sale could be a routine portfolio rebalancing unrelated to company outlook.

Key entities

  • Company
    Tenet Healthcare Corp

    U.S. healthcare services provider (ticker THC).

  • Individual
    Kerrey J. Robert

    Director of Tenet Healthcare who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

THC insider trading history →

Related articles

SEP 9
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders

Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.

simplywall.st2 min
SEP 9
$THCMedAI 8/10

Tenet Healthcare at Wells Fargo conference: high-acuity push deepens

Tenet Healthcare (THC) presented at the Wells Fargo Healthcare Conference, outlining a strategy focused on high-acuity care, capital spending, and cost control. The company raised full-year guidance, citing volume growth and cost discipline. Shares are near their 52-week high at $268.82, up over 30% year-to-date. Tenet expects continued pressure in some payer channels and near-term earnings drag from Conifer's transition. Management plans to invest in complex procedures and maintain capital spen

uk.investing.com2 min